Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of "eye stroke" (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side ...

The results of this obesity medication are literally eye-popping. A new review of adverse effects reports to the FDA between ...

Eye strokes’ that reduce blood flow to optic nerve likely to be side-effect of active ingredient semaglutide, says author ...

Wegovy may raise the risk of "eye stroke" and vision loss, especially in men, compared to Ozempic due to higher doses of the ...

NAION is often referred to as an ‘eye stroke’, it causes sudden, painless vision loss - usually in one eye, but sometimes in both eyes.

NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy) officially describes vision loss caused by reduced blood flow to the optic nerve ...

Ozempic blindness isn’t a real diagnosis. It’s a nickname used to describe sudden vision loss that may be linked to the weight loss drugs semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, ...

SLIMMERS taking the weight loss Wegovy may be at highest risk of a debilitating eye condition that leads to permanent vision loss, research shows. Semaglutide — the powerful ingredient behind ...

A growing wave of lawsuits is targeting Novo Nordisk, the manufacturer of the widely used drugs Ozempic and Wegovy, following a recent study that suggests a link between the medications and a sudden, ...

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for type 2 diabetes and weight loss. Medications such as Ozempic, Wegovy, Mounjaro ...

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare eye condition known as NAION (non-arteritic anterior ischemic optic ...